食管-话题@MedSci

#食管#

815篇内容 | 2458人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1437669, encodeId=2fb7143e669f8, content=<a href='/topic/show?id=0e311010591a' target=_blank style='color:#2F92EE;'>#食管#</a>, objectTitle=Br J Cancer：人群队列研究揭示更年期激素治疗可降低食管腺癌患病风险, objectType=article, longId=219398, objectId=db08219398f4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=db08219398f4, replyNumber=0, likeNumber=121, createdTime=2021-10-29, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=db08219398f4, moduleTitle=Br J Cancer：人群队列研究揭示更年期激素治疗可降低食管腺癌患病风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=db08219398f4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1437668, encodeId=2098143e66875, content=<a href='/topic/show?id=0e311010591a' target=_blank style='color:#2F92EE;'>#食管#</a>, objectTitle=Nat Genet：食管鳞状细胞癌的突变特征研究, objectType=article, longId=219395, objectId=1cfd2193952c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1cfd2193952c, replyNumber=0, likeNumber=77, createdTime=2021-10-29, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1cfd2193952c, moduleTitle=Nat Genet：食管鳞状细胞癌的突变特征研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1cfd2193952c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1437667, encodeId=75ce143e6673e, content=<a href='/topic/show?id=0e311010591a' target=_blank style='color:#2F92EE;'>#食管#</a>, objectTitle=Cancer Commun：抗HER2抗体RC48治疗HER2过表达晚期胃癌(GC)或胃食管交界处癌(GEJA)的疗效和安全性：单臂II期研究, objectType=article, longId=219112, objectId=3ad22191126f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3ad22191126f, replyNumber=0, likeNumber=85, createdTime=2021-10-25, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3ad22191126f, moduleTitle=Cancer Commun：抗HER2抗体RC48治疗HER2过表达晚期胃癌(GC)或胃食管交界处癌(GEJA)的疗效和安全性：单臂II期研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3ad22191126f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1437666, encodeId=96df143e66625, content=<a href='/topic/show?id=0e311010591a' target=_blank style='color:#2F92EE;'>#食管#</a>, objectTitle=Front Oncol：食管切除术和非食管切除术对T1期食管癌患者的长期预后影响, objectType=article, longId=218617, objectId=91f321861ea2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=91f321861ea2, replyNumber=0, likeNumber=72, createdTime=2021-10-16, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=91f321861ea2, moduleTitle=Front Oncol：食管切除术和非食管切除术对T1期食管癌患者的长期预后影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=91f321861ea2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1437665, encodeId=b8cc143e66562, content=<a href='/topic/show?id=0e311010591a' target=_blank style='color:#2F92EE;'>#食管#</a>, objectTitle=Gastric Cancer：纳武利尤单抗（nivolumab）治疗不能切除的晚期或复发的胃/胃食管连接处癌（G/GEJ）的疗效和安全性：来自日本的真实研究数据, objectType=article, longId=217859, objectId=d2a621e8599c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d2a621e8599c, replyNumber=0, likeNumber=68, createdTime=2021-09-30, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d2a621e8599c, moduleTitle=Gastric Cancer：纳武利尤单抗（nivolumab）治疗不能切除的晚期或复发的胃/胃食管连接处癌（G/GEJ）的疗效和安全性：来自日本的真实研究数据, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d2a621e8599c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1437664, encodeId=0f79143e664f3, content=<a href='/topic/show?id=0e311010591a' target=_blank style='color:#2F92EE;'>#食管#</a>, objectTitle=Clin Gastroenterology H: STAT6变异与接受长期质子泵抑制剂治疗的患者的嗜酸性粒细胞性食管炎复发有关, objectType=article, longId=217646, objectId=910c21e6469c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=910c21e6469c, replyNumber=0, likeNumber=84, createdTime=2021-09-27, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=910c21e6469c, moduleTitle=Clin Gastroenterology H: STAT6变异与接受长期质子泵抑制剂治疗的患者的嗜酸性粒细胞性食管炎复发有关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=910c21e6469c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1437663, encodeId=b75c143e66399, content=<a href='/topic/show?id=0e311010591a' target=_blank style='color:#2F92EE;'>#食管#</a>, objectTitle=信迪利单抗联合化疗一线治疗食管鳞癌的Ⅲ期临床研究结果公布（ORIENT-15研究）, objectType=article, longId=217411, objectId=2e6921e411bd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2e6921e411bd, replyNumber=0, likeNumber=101, createdTime=2021-09-23, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2e6921e411bd, moduleTitle=信迪利单抗联合化疗一线治疗食管鳞癌的Ⅲ期临床研究结果公布（ORIENT-15研究）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2e6921e411bd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1437662, encodeId=24e4143e662ca, content=<a href='/topic/show?id=0e311010591a' target=_blank style='color:#2F92EE;'>#食管#</a>, objectTitle=ESMO 2021：特瑞普利单抗一线治疗食管癌的Ⅲ期临床研究结果公布，OS高达17个月, objectType=article, longId=217409, objectId=8a7b21e409e8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8a7b21e409e8, replyNumber=0, likeNumber=79, createdTime=2021-09-23, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8a7b21e409e8, moduleTitle=ESMO 2021：特瑞普利单抗一线治疗食管癌的Ⅲ期临床研究结果公布，OS高达17个月, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8a7b21e409e8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1437661, encodeId=bb2b143e661b2, content=<a href='/topic/show?id=0e311010591a' target=_blank style='color:#2F92EE;'>#食管#</a>, objectTitle=Front Oncol： PD-L1抑制剂durvalumab用于局部进展期食管和胃食管连接处腺癌术后辅助治疗的疗效：II期临床研究, objectType=article, longId=217312, objectId=e46321e31264, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e46321e31264, replyNumber=0, likeNumber=22, createdTime=2021-09-20, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e46321e31264, moduleTitle=Front Oncol： PD-L1抑制剂durvalumab用于局部进展期食管和胃食管连接处腺癌术后辅助治疗的疗效：II期临床研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e46321e31264)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1437660, encodeId=e8bd143e660ca, content=<a href='/topic/show?id=0e311010591a' target=_blank style='color:#2F92EE;'>#食管#</a>, objectTitle=JAMA |我国学者：卡瑞丽珠单抗降低晚期食管癌患者3成生存率、4成无进展生存！, objectType=article, longId=217252, objectId=af4221e2529b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=af4221e2529b, replyNumber=0, likeNumber=92, createdTime=2021-09-19, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=af4221e2529b, moduleTitle=JAMA |我国学者：卡瑞丽珠单抗降低晚期食管癌患者3成生存率、4成无进展生存！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=af4221e2529b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1437659, encodeId=1975143e6592d, content=<a href='/topic/show?id=0e311010591a' target=_blank style='color:#2F92EE;'>#食管#</a>, objectTitle=JAMA：卡瑞丽珠单抗联合化疗一线治疗明显改善晚期食管鳞状细胞癌患者的预后：3期临床研究ESCORT-1st, objectType=article, longId=217175, objectId=e7b321e1759e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e7b321e1759e, replyNumber=0, likeNumber=83, createdTime=2021-09-17, rootId=0, userName=柳叶一刀, userId=778d36, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e7b321e1759e, moduleTitle=JAMA：卡瑞丽珠单抗联合化疗一线治疗明显改善晚期食管鳞状细胞癌患者的预后：3期临床研究ESCORT-1st, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e7b321e1759e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1437658, encodeId=af25143e65892, content=<a href='/topic/show?id=0e311010591a' target=_blank style='color:#2F92EE;'>#食管#</a>, objectTitle=Stroke：脑中风后，经食管心脏超声，有何益处？, objectType=article, longId=217144, objectId=5b9821e144bb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5b9821e144bb, replyNumber=0, likeNumber=58, createdTime=2021-09-16, rootId=0, userName=柳叶一刀, userId=778d36, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5b9821e144bb, moduleTitle=Stroke：脑中风后，经食管心脏超声，有何益处？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5b9821e144bb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1437657, encodeId=8286143e65770, content=<a href='/topic/show?id=0e311010591a' target=_blank style='color:#2F92EE;'>#食管#</a>, objectTitle=Gastric Cancer：帕博利珠单抗（Pembrolizumab）vs 紫杉醇治疗既往治疗过PD-L1阳性胃或胃食管连接处癌的疗效：III期临床研究KEYNOTE‑061的2年更新结果, objectType=article, longId=216988, objectId=2a7f21698850, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2a7f21698850, replyNumber=0, likeNumber=25, createdTime=2021-09-13, rootId=0, userName=柳叶一刀, userId=778d36, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2a7f21698850, moduleTitle=Gastric Cancer：帕博利珠单抗（Pembrolizumab）vs 紫杉醇治疗既往治疗过PD-L1阳性胃或胃食管连接处癌的疗效：III期临床研究KEYNOTE‑061的2年更新结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2a7f21698850)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1437656, encodeId=a015143e65691, content=<a href='/topic/show?id=0e311010591a' target=_blank style='color:#2F92EE;'>#食管#</a>, objectTitle=Ann Surg：胃食管吻合技术哪家强？改良的Collard技术 PK 圆形吻合技术, objectType=article, longId=216626, objectId=d242216626b7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d242216626b7, replyNumber=0, likeNumber=81, createdTime=2021-09-04, rootId=0, userName=柳叶一刀, userId=778d36, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d242216626b7, moduleTitle=Ann Surg：胃食管吻合技术哪家强？改良的Collard技术 PK 圆形吻合技术, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d242216626b7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1437655, encodeId=51c5143e655c2, content=<a href='/topic/show?id=0e311010591a' target=_blank style='color:#2F92EE;'>#食管#</a>, objectTitle=Lancet：全球半数病例在中国，K药为食管癌患者带来好消息！, objectType=article, longId=216447, objectId=c37e21644ef7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c37e21644ef7, replyNumber=0, likeNumber=55, createdTime=2021-08-31, rootId=0, userName=柳叶一刀, userId=778d36, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c37e21644ef7, moduleTitle=Lancet：全球半数病例在中国，K药为食管癌患者带来好消息！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c37e21644ef7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1437654, encodeId=0129143e65426, content=<a href='/topic/show?id=0e311010591a' target=_blank style='color:#2F92EE;'>#食管#</a>, objectTitle=Eur J Cancer：胃食管癌一线治疗效果与二线治疗结果的相关性, objectType=article, longId=216405, objectId=ebbc216405c0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ebbc216405c0, replyNumber=0, likeNumber=85, createdTime=2021-08-29, rootId=0, userName=柳叶一刀, userId=778d36, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ebbc216405c0, moduleTitle=Eur J Cancer：胃食管癌一线治疗效果与二线治疗结果的相关性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ebbc216405c0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1437653, encodeId=108f143e653ce, content=<a href='/topic/show?id=0e311010591a' target=_blank style='color:#2F92EE;'>#食管#</a>, objectTitle=Gastroenterology：Barrett食管患者多大年龄时可停止进行内镜监测？, objectType=article, longId=215860, objectId=f45b215860fd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f45b215860fd, replyNumber=0, likeNumber=76, createdTime=2021-08-18, rootId=0, userName=柳叶一刀, userId=778d36, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f45b215860fd, moduleTitle=Gastroenterology：Barrett食管患者多大年龄时可停止进行内镜监测？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f45b215860fd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1437652, encodeId=461c143e6525e, content=<a href='/topic/show?id=0e311010591a' target=_blank style='color:#2F92EE;'>#食管#</a>, objectTitle=Gastroenterology：颠覆！T1bN0M期食管鳞癌患者采用放化疗治疗的效果不劣于手术！, objectType=article, longId=215857, objectId=3a0b21585eec, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3a0b21585eec, replyNumber=0, likeNumber=90, createdTime=2021-08-18, rootId=0, userName=柳叶一刀, userId=778d36, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3a0b21585eec, moduleTitle=Gastroenterology：颠覆！T1bN0M期食管鳞癌患者采用放化疗治疗的效果不劣于手术！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3a0b21585eec)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1437651, encodeId=3a94143e65104, content=<a href='/topic/show?id=0e311010591a' target=_blank style='color:#2F92EE;'>#食管#</a>, objectTitle=Ann Surg：喉返神经监测可改善食管癌切除术中淋巴结的清扫效果, objectType=article, longId=215263, objectId=38f521526358, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=38f521526358, replyNumber=0, likeNumber=71, createdTime=2021-08-05, rootId=0, userName=柳叶一刀, userId=778d36, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=38f521526358, moduleTitle=Ann Surg：喉返神经监测可改善食管癌切除术中淋巴结的清扫效果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=38f521526358)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1437650, encodeId=e046143e6509e, content=<a href='/topic/show?id=0e311010591a' target=_blank style='color:#2F92EE;'>#食管#</a>, objectTitle=Br J Cancer：阿司匹林增强顺铂治疗食管鳞癌的疗效, objectType=article, longId=215172, objectId=d9d42151e26a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d9d42151e26a, replyNumber=0, likeNumber=77, createdTime=2021-08-03, rootId=0, userName=柳叶一刀, userId=778d36, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d9d42151e26a, moduleTitle=Br J Cancer：阿司匹林增强顺铂治疗食管鳞癌的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d9d42151e26a)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

食管

2020-05-29

zhouqu_8 (审核中...)

前往app查看评论内容

#食管#

Br J Cancer：人群队列研究揭示更年期激素治疗可降低食管腺癌患病风险

2021-10-29

zhouqu_8 (审核中...)

前往app查看评论内容

#食管#

Nat Genet：食管鳞状细胞癌的突变特征研究

2021-10-29

zhouqu_8 (审核中...)

前往app查看评论内容

#食管#

Cancer Commun：抗HER2抗体RC48治疗HER2过表达晚期胃癌(GC)或胃食管交界处癌(GEJA)的疗效和安全性：单臂II期研究

2021-10-25

zhouqu_8 (审核中...)

前往app查看评论内容

#食管#

Front Oncol：食管切除术和非食管切除术对T1期食管癌患者的长期预后影响

2021-10-16

zhouqu_8 (审核中...)

前往app查看评论内容

#食管#

Gastric Cancer：纳武利尤单抗（nivolumab）治疗不能切除的晚期或复发的胃/胃食管连接处癌（G/GEJ）的疗效和安全性：来自日本的真实研究数据

2021-09-30

zhouqu_8 (审核中...)

前往app查看评论内容

#食管#

Clin Gastroenterology H: STAT6变异与接受长期质子泵抑制剂治疗的患者的嗜酸性粒细胞性食管炎复发有关

2021-09-27

zhouqu_8 (审核中...)

前往app查看评论内容

#食管#

信迪利单抗联合化疗一线治疗食管鳞癌的Ⅲ期临床研究结果公布（ORIENT-15研究）

2021-09-23

zhouqu_8 (审核中...)

前往app查看评论内容

#食管#

ESMO 2021：特瑞普利单抗一线治疗食管癌的Ⅲ期临床研究结果公布，OS高达17个月

2021-09-23

zhouqu_8 (审核中...)

前往app查看评论内容

#食管#

Front Oncol： PD-L1抑制剂durvalumab用于局部进展期食管和胃食管连接处腺癌术后辅助治疗的疗效：II期临床研究

2021-09-20

zhouqu_8 (审核中...)

前往app查看评论内容

#食管#

JAMA |我国学者：卡瑞丽珠单抗降低晚期食管癌患者3成生存率、4成无进展生存！

2021-09-19

柳叶一刀 (审核中...)

前往app查看评论内容

#食管#

JAMA：卡瑞丽珠单抗联合化疗一线治疗明显改善晚期食管鳞状细胞癌患者的预后：3期临床研究ESCORT-1st

2021-09-17

柳叶一刀 (审核中...)

前往app查看评论内容

#食管#

Stroke：脑中风后，经食管心脏超声，有何益处？

2021-09-16

柳叶一刀 (审核中...)

前往app查看评论内容

#食管#

Gastric Cancer：帕博利珠单抗（Pembrolizumab）vs 紫杉醇治疗既往治疗过PD-L1阳性胃或胃食管连接处癌的疗效：III期临床研究KEYNOTE‑061的2年更新结果

2021-09-13

柳叶一刀 (审核中...)

前往app查看评论内容

#食管#

Ann Surg：胃食管吻合技术哪家强？改良的Collard技术 PK 圆形吻合技术

2021-09-04

柳叶一刀 (审核中...)

前往app查看评论内容

#食管#

Lancet：全球半数病例在中国，K药为食管癌患者带来好消息！

2021-08-31

柳叶一刀 (审核中...)

前往app查看评论内容

#食管#

Eur J Cancer：胃食管癌一线治疗效果与二线治疗结果的相关性

2021-08-29

柳叶一刀 (审核中...)

前往app查看评论内容

#食管#

Gastroenterology：Barrett食管患者多大年龄时可停止进行内镜监测？

2021-08-18

柳叶一刀 (审核中...)

前往app查看评论内容

#食管#

Gastroenterology：颠覆！T1bN0M期食管鳞癌患者采用放化疗治疗的效果不劣于手术！

2021-08-18

柳叶一刀 (审核中...)

前往app查看评论内容

#食管#

Ann Surg：喉返神经监测可改善食管癌切除术中淋巴结的清扫效果

2021-08-05

柳叶一刀 (审核中...)

前往app查看评论内容

#食管#

Br J Cancer：阿司匹林增强顺铂治疗食管鳞癌的疗效

2021-08-03

科室
- - 订阅+
  - 更多科室
工具
服务